foxo4-dri for senescent cells — ≥99% Purity, COA Included Development of a novel senolytic
Description
Patients with benign prostatic hypertrophy may develop acute urethral obstruction
* Entries in each column identified by a, b, c, d differ significantly (Duncan's multiple-range test, P 15mm in diameter on ultrasound (28)
Pack Size
The diagnosis must clearly justify the procedure
Dihexa remains an investigational compound and is not FDA-approved for medical use
Int J Mol Sci 22:125
